✦ LIBER ✦

A randomized, double-blind, placebo- and active-controlled phase III study of tapentadol ER for chronic low back pain: analysis of efficacy endpoint sensitivity

✍ Scribed by M. Etropolski; C. Rauschkolb-Löffler; D. Shapiro; A. Okamoto; C. Lange

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Efficacy and safety of tapentadol ER for

✍ R. Buynak; D. Shapiro; A. Okamoto; I. Van Hove; M. Etropolski 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 34 KB

Efficacy, safety, and gastrointestinal t

✍ R. Buynak; D. Shapiro; A. Okamoto; C. Lange; M. Etropolski 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 35 KB

Efficacy and safety of oxymorphone exten

✍ Martin E. Hale; Chris Dvergsten; Joseph Gimbel 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 180 KB

Poster 48: Gastrointestinal Tolerability

✍ Douglas Shapiro; Robert Buynak; Mila S. Etropolski; Claudia Lange; Akiko Okamoto 📂 Article 📅 2009 🏛 Wiley (John Wiley & Sons) 🌐 English ⚖ 52 KB

Pulsed Radiofrequency of Suprascapular N

✍ Michael Gofeld; Carlos E. Restrepo-Garces; Brian R. Theodore; Gil Faclier 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 172 KB

Cyclobenzaprine ER for muscle spasm asso

✍ Malanga, Gerard A.; Ruoff, Gary E.; Weil, Arnold J.; Altman, Charles A.; Xie, Fa 📂 Article 📅 2009 🏛 Informa plc 🌐 English ⚖ 435 KB